首页 > 最新文献

Journal of Laboratory Physicians最新文献

英文 中文
Salivary IgA as a Surrogate Biomarker for Microbial Infections in Postoperative Patients Receiving Chemo-Radio-Therapy for Head and Neck Cancer. 唾液IgA作为头颈癌术后化疗患者微生物感染的替代生物标志物
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1757720
Preeti Chavan, Vivek Bhat, Amit Joshi, Tejpal Gupta, Vedang Murthy, Vanita Noronha, Divya Rathish, Kumar Prabhash

Objective  Radiotherapy (RT) and chemotherapy (CT) are important treatment options in patients with head and neck cancers. A common complication of this is microbial colonization or infection of mucosal surfaces. These infections may commonly be due to bacteria or yeasts. Salivary proteins with their buffering activity and immunoglobulin, especially immunoglobulin A (IgA), protect oral tissue, mucosal surfaces, and teeth from various microorganisms. This study characterizes the common microorganisms encountered and evaluates the role of salivary IgA in predicting microbial infections in this group of patients with mucositis. Methods  A total of 150 adult head and neck cancer patients on CTRT were evaluated at baseline and at the end of 3 and 6 weeks, respectively. Oral swabs collected from buccal mucosa were processed in the microbiology laboratory for the presence of microorganisms. Saliva was processed for IgA level estimation on Siemens Dimension Automated biochemistry analyzer. ResultsPseudomonas aeruginosa and Klebsiella pneumonia e were the most common organisms found in our patients, followed by Escherichia coli and group A beta-hemolytic Streptococci . A significant increase ( p  = 0.0203) in the incidence of bacterial infection was observed in post-CTRT patients (61%) compared to pre-CTRT patients (49.33%). There was significant increase in levels of salivary IgA ( p  = 0.003) in patients with bacterial and fungal infection ( n  = 135/267) when compared to those in samples showing no growth ( n  = 66/183). Conclusion  A significant increase in the incidence of bacterial infection in post-CTRT patients was observed in this study. This study also indicated that postoperative head and neck cancer patients with oral mucositis that developed an infection were associated with high salivary IgA levels, and it may serve as a surrogate biomarker of infection in these patients.

目的放疗(RT)和化疗(CT)是头颈部肿瘤治疗的重要选择。常见的并发症是微生物定植或粘膜表面感染。这些感染通常是由细菌或酵母引起的。唾液蛋白具有缓冲活性和免疫球蛋白,特别是免疫球蛋白A (IgA),保护口腔组织、粘膜表面和牙齿免受各种微生物的侵害。本研究描述了常见的微生物,并评估了唾液IgA在预测这组粘膜炎患者微生物感染中的作用。方法对150例接受CTRT治疗的成人头颈癌患者,分别在治疗前、治疗3周和治疗6周进行评估。从口腔黏膜收集的口腔拭子在微生物实验室进行微生物处理。唾液经西门子维格自动化生化分析仪检测IgA水平。结果铜绿假单胞菌和肺炎克雷伯菌是本组患者最常见的病原菌,其次是大肠杆菌和A群溶血链球菌。ctrt后患者的细菌感染发生率(61%)较ctrt前患者(49.33%)显著增加(p = 0.0203)。细菌和真菌感染患者(n = 135/267)的唾液IgA水平与未感染患者(n = 66/183)相比显著升高(p = 0.003)。结论在本研究中观察到ctrt后患者细菌感染的发生率明显增加。本研究还表明,头颈癌术后口腔黏膜炎患者发生感染与高唾液IgA水平相关,它可能作为这些患者感染的替代生物标志物。
{"title":"Salivary IgA as a Surrogate Biomarker for Microbial Infections in Postoperative Patients Receiving Chemo-Radio-Therapy for Head and Neck Cancer.","authors":"Preeti Chavan,&nbsp;Vivek Bhat,&nbsp;Amit Joshi,&nbsp;Tejpal Gupta,&nbsp;Vedang Murthy,&nbsp;Vanita Noronha,&nbsp;Divya Rathish,&nbsp;Kumar Prabhash","doi":"10.1055/s-0042-1757720","DOIUrl":"https://doi.org/10.1055/s-0042-1757720","url":null,"abstract":"<p><p><b>Objective</b>  Radiotherapy (RT) and chemotherapy (CT) are important treatment options in patients with head and neck cancers. A common complication of this is microbial colonization or infection of mucosal surfaces. These infections may commonly be due to bacteria or yeasts. Salivary proteins with their buffering activity and immunoglobulin, especially immunoglobulin A (IgA), protect oral tissue, mucosal surfaces, and teeth from various microorganisms. This study characterizes the common microorganisms encountered and evaluates the role of salivary IgA in predicting microbial infections in this group of patients with mucositis. <b>Methods</b>  A total of 150 adult head and neck cancer patients on CTRT were evaluated at baseline and at the end of 3 and 6 weeks, respectively. Oral swabs collected from buccal mucosa were processed in the microbiology laboratory for the presence of microorganisms. Saliva was processed for IgA level estimation on Siemens Dimension Automated biochemistry analyzer. <b>Results</b>   <i>Pseudomonas aeruginosa</i> and <i>Klebsiella pneumonia</i> e were the most common organisms found in our patients, followed by <i>Escherichia coli</i> and group A beta-hemolytic <i>Streptococci</i> . A significant increase ( <i>p</i>  = 0.0203) in the incidence of bacterial infection was observed in post-CTRT patients (61%) compared to pre-CTRT patients (49.33%). There was significant increase in levels of salivary IgA ( <i>p</i>  = 0.003) in patients with bacterial and fungal infection ( <i>n</i>  = 135/267) when compared to those in samples showing no growth ( <i>n</i>  = 66/183). <b>Conclusion</b>  A significant increase in the incidence of bacterial infection in post-CTRT patients was observed in this study. This study also indicated that postoperative head and neck cancer patients with oral mucositis that developed an infection were associated with high salivary IgA levels, and it may serve as a surrogate biomarker of infection in these patients.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"264-268"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e2/7e/10-1055-s-0042-1757720.PMC10264106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluating Interference of Lipemia on Routine Clinical Biochemical Tests. 评价血脂对常规临床生化试验的干扰。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1758664
Subramaniam ArulVijayaVani, Palani Selvam Mohanraj, Rajagambeeram Reeta

Objective  Lipemia is an important cause of preanalytical errors in laboratory results. They affect the specimen integrity and trustworthiness of laboratory results. The present study was to assess the impact of lipemia on routine clinical chemistry analytes. Methods  Anonymous leftover serum samples with normal levels of routine biochemical parameters were pooled. Twenty such pooled serum samples were used for the study. The samples were spiked with commercially available intralipid solution (20%) to produce lipemic concentrations of 0, 400 (mild, 20 μL), 1,000 (moderate, 50 μL), and 2,000 mg/dL (severe, 100 μL). Glucose, renal function test, electrolytes, and liver function test were estimated in all the samples. Baseline data without the effect of interference was considered as true value and percentage bias for the spiked samples was calculated. Interference was considered significant if the interference bias percentage exceeded 10%. Result  Parameters like glucose, urea, creatinine, direct bilirubin, sodium, potassium, and chloride showed negative interference at mild and moderate lipemic concentration and positive interference at severe lipemic concentration. Parameters like aspartate transaminase (AST) and alanine transaminase (ALT) showed negative interference at mild and positive interference at moderate and severe lipemic concentration. Whereas uric acid, total protein, albumin, total bilirubin, alkaline phosphatase, gamma-glutamyl transferase, calcium, magnesium, and phosphorous showed positive interference at all concentrations. Significant interference (> 10%) was shown for magnesium (mild lipemia), albumin, direct bilirubin, ALT, and AST at moderate lipemic concentration. All parameters showed significant interference at severe lipemic concentration. Conclusion  All the study parameters are affected by lipemic interference at varying levels. Laboratory-specific data regarding lipemic interference at various concentrations on the clinical biochemistry parameters is needed.

目的脂血症是导致实验室分析前误差的重要原因。它们影响标本的完整性和实验室结果的可信度。本研究旨在评估血脂对常规临床化学分析的影响。方法收集常规生化指标正常的匿名剩余血清样本。这项研究使用了20个这样的血清样本。将样品用市售的脂内溶液(20%)加标,得到的脂质浓度分别为0,400(轻度,20 μL), 1,000(中度,50 μL)和2,000 mg/dL(重度,100 μL)。对所有样本进行葡萄糖、肾功能、电解质和肝功能检测。不受干扰影响的基线数据被认为是真实值,并计算加标样品的百分比偏差。如果干扰偏差百分比超过10%,则认为干扰显著。结果葡萄糖、尿素、肌酐、直接胆红素、钠、钾、氯等参数在轻、中度脂血浓度时呈负干扰,在重度脂血浓度时呈正干扰。谷草转氨酶(AST)和丙氨酸转氨酶(ALT)等参数在轻度时表现为负干扰,在中度和重度血脂浓度时表现为正干扰。而尿酸、总蛋白、白蛋白、总胆红素、碱性磷酸酶、γ -谷氨酰转移酶、钙、镁和磷在所有浓度下均表现为正干扰。在中度血脂浓度下,镁(轻度脂血症)、白蛋白、直接胆红素、ALT和AST的干扰显著(> 10%)。在严重的血脂浓度下,所有参数都显示出显著的干扰。结论血脂干扰对各项指标均有不同程度的影响。需要关于不同浓度的血脂干扰对临床生化参数的实验室特定数据。
{"title":"Evaluating Interference of Lipemia on Routine Clinical Biochemical Tests.","authors":"Subramaniam ArulVijayaVani,&nbsp;Palani Selvam Mohanraj,&nbsp;Rajagambeeram Reeta","doi":"10.1055/s-0042-1758664","DOIUrl":"https://doi.org/10.1055/s-0042-1758664","url":null,"abstract":"<p><p><b>Objective</b>  Lipemia is an important cause of preanalytical errors in laboratory results. They affect the specimen integrity and trustworthiness of laboratory results. The present study was to assess the impact of lipemia on routine clinical chemistry analytes. <b>Methods</b>  Anonymous leftover serum samples with normal levels of routine biochemical parameters were pooled. Twenty such pooled serum samples were used for the study. The samples were spiked with commercially available intralipid solution (20%) to produce lipemic concentrations of 0, 400 (mild, 20 μL), 1,000 (moderate, 50 μL), and 2,000 mg/dL (severe, 100 μL). Glucose, renal function test, electrolytes, and liver function test were estimated in all the samples. Baseline data without the effect of interference was considered as true value and percentage bias for the spiked samples was calculated. Interference was considered significant if the interference bias percentage exceeded 10%. <b>Result</b>  Parameters like glucose, urea, creatinine, direct bilirubin, sodium, potassium, and chloride showed negative interference at mild and moderate lipemic concentration and positive interference at severe lipemic concentration. Parameters like aspartate transaminase (AST) and alanine transaminase (ALT) showed negative interference at mild and positive interference at moderate and severe lipemic concentration. Whereas uric acid, total protein, albumin, total bilirubin, alkaline phosphatase, gamma-glutamyl transferase, calcium, magnesium, and phosphorous showed positive interference at all concentrations. Significant interference (> 10%) was shown for magnesium (mild lipemia), albumin, direct bilirubin, ALT, and AST at moderate lipemic concentration. All parameters showed significant interference at severe lipemic concentration. <b>Conclusion</b>  All the study parameters are affected by lipemic interference at varying levels. Laboratory-specific data regarding lipemic interference at various concentrations on the clinical biochemistry parameters is needed.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"269-275"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/cc/10-1055-s-0042-1758664.PMC10264112.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amelanotic Melanoma: A Great Masquerader. 无黑色素瘤:一个伟大的假面舞者。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1757236
Md Ali Osama, Seema Rao, Neha Bakshi, Sonia Badwal, Shyam Aggarwal

Malignant melanoma is an aggressive, notorious tumor showing great variability in morphological and immunohistochemical expression, thus commonly leading to an erroneous diagnosis. Within the melanoma group, amelanotic melanoma, with its wide clinical presentations, lack of pigmentation, and varied histological appearances, has taken on a new persona as a master masquerader. Use of immunohistochemistry in the diagnosis of malignant tumors, including melanoma, is primordial and indispensable. However, the problem gets compounded in scenario of aberrant antigenic expression. The present case posed multiple diagnostic challenges in form of atypical clinical presentation, variant morphology, as well as aberrant antigenic expression. Here, we present the case of a 72-year-old male who, upon his initial presentation, was thought to be sarcomatoid anaplastic plasmacytoma, but 5 months later another biopsy from a different site revealed the actual diagnosis of amelanotic melanoma.

恶性黑色素瘤是一种侵袭性的、臭名昭著的肿瘤,在形态和免疫组织化学表达上表现出很大的可变性,因此通常会导致错误的诊断。在黑色素瘤组中,无色素黑色素瘤以其广泛的临床表现、缺乏色素沉着和多样的组织学外观,已经成为一种新的伪装大师。使用免疫组织化学诊断恶性肿瘤,包括黑色素瘤,是原始的和不可或缺的。然而,在抗原表达异常的情况下,问题变得更加复杂。本病例提出了多种诊断挑战的形式,不典型的临床表现,变异形态,以及异常抗原表达。在这里,我们报告一位72岁的男性患者,在他最初的表现时,被认为是肉瘤样间变性浆细胞瘤,但5个月后,另一次来自不同部位的活检显示实际诊断为无色素瘤黑色素瘤。
{"title":"Amelanotic Melanoma: A Great Masquerader.","authors":"Md Ali Osama,&nbsp;Seema Rao,&nbsp;Neha Bakshi,&nbsp;Sonia Badwal,&nbsp;Shyam Aggarwal","doi":"10.1055/s-0042-1757236","DOIUrl":"https://doi.org/10.1055/s-0042-1757236","url":null,"abstract":"<p><p>Malignant melanoma is an aggressive, notorious tumor showing great variability in morphological and immunohistochemical expression, thus commonly leading to an erroneous diagnosis. Within the melanoma group, amelanotic melanoma, with its wide clinical presentations, lack of pigmentation, and varied histological appearances, has taken on a new persona as a master masquerader. Use of immunohistochemistry in the diagnosis of malignant tumors, including melanoma, is primordial and indispensable. However, the problem gets compounded in scenario of aberrant antigenic expression. The present case posed multiple diagnostic challenges in form of atypical clinical presentation, variant morphology, as well as aberrant antigenic expression. Here, we present the case of a 72-year-old male who, upon his initial presentation, was thought to be sarcomatoid anaplastic plasmacytoma, but 5 months later another biopsy from a different site revealed the actual diagnosis of amelanotic melanoma.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"300-305"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cb/b1/10-1055-s-0042-1757236.PMC10264121.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variable Virulence Genes in Clinical Isolates of Burkholderia pseudomallei : Impact on Disease Severity and Outcome in Melioidosis. 假马利氏伯克氏菌临床分离株的可变毒力基因:对类鼻疽疾病严重程度和结局的影响。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1760667
Sruthi Raj, Sujatha Sistla, Deepthy Melepurakkal Sadanandan, Sreeram Chandra Murthy Peela

Objectives  To isolate Burkholderia pseudomallei from clinical specimens and study the association of virulence genes with clinical manifestations and outcome in patients with melioidosis. Materials and MethodsBurkholderia pseudomallei isolates obtained from melioidosis cases diagnosed during 2018 to 2021 were identified using VITEK 2 system and confirmed by polymerase chain reaction (PCR) targeting a Type III secretion system gene cluster. Multiplex PCR was performed to detect the genotypes of lipopolysaccharide (LPS) namely A, B, and B2, and singleplex PCR was performed to detect the presence of the Burkholderia intracellular motility gene ( BimA ) and filamentous hemagglutinin gene ( fhaB3 ). Statistical Analysis  Chi-square/Fisher's exact tests were performed to study the association between various clinical manifestations and outcome and different virulence genes. The results were expressed as unadjusted odds ratios with 95% confidence intervals. Results  Sixty-seven isolates were available for characterization. BimA Bm and BimA Bp were observed among 82 and 18% of the isolates, respectively. Both sepsis and mortality were significantly associated with BimA Bm . Majority of the isolates had fhaB3 (97%). Most of the isolates showed the presence of LPS A gene (65.7%) followed by LPS B gene (6%), while LPS B2 was not detected. Nineteen isolates could not be assigned to any LPS genotypes. Conclusion  Among the virulence genes studied, only BimA Bm was significantly associated with sepsis and mortality. More than a quarter (28.3%) of the isolates could not be assigned to any LPS genotypes, hinting at a greater genetic diversity in our isolates.

目的从临床标本中分离假马利氏伯克氏菌,研究其毒力基因与类鼻疽患者临床表现及转归的关系。材料与方法采用VITEK 2系统对2018 - 2021年诊断的类鼻疽病患者分离株进行鉴定,并对III型分泌系统基因簇进行聚合酶链反应(PCR)鉴定。采用多重PCR检测脂多糖(LPS) A、B、B2基因型,采用单路PCR检测伯克霍尔德氏菌胞内运动基因(BimA)和丝状血凝素基因(fhaB3)的存在。统计学分析采用卡方/Fisher精确检验研究各种临床表现和转归与不同毒力基因之间的关系。结果用95%置信区间的未调整优势比表示。结果67株菌株可鉴定。BimA - Bm和BimA - Bp分别占82%和18%。脓毒症和死亡率均与BimA - Bm显著相关。大多数分离株含有fhaB3(97%)。多数菌株存在LPS A基因(65.7%),其次为LPS B基因(6%),未检出LPS B2基因。19株分离株不能归属于任何LPS基因型。结论在研究的毒力基因中,只有BimA - Bm与脓毒症和死亡率显著相关。超过四分之一(28.3%)的分离株不能被分配到任何LPS基因型,这表明我们的分离株具有更大的遗传多样性。
{"title":"Variable Virulence Genes in Clinical Isolates of <i>Burkholderia pseudomallei</i> : Impact on Disease Severity and Outcome in Melioidosis.","authors":"Sruthi Raj,&nbsp;Sujatha Sistla,&nbsp;Deepthy Melepurakkal Sadanandan,&nbsp;Sreeram Chandra Murthy Peela","doi":"10.1055/s-0042-1760667","DOIUrl":"https://doi.org/10.1055/s-0042-1760667","url":null,"abstract":"<p><p><b>Objectives</b>  To isolate <i>Burkholderia pseudomallei</i> from clinical specimens and study the association of virulence genes with clinical manifestations and outcome in patients with melioidosis. <b>Materials and Methods</b>   <i>Burkholderia</i> <i>pseudomallei</i> isolates obtained from melioidosis cases diagnosed during 2018 to 2021 were identified using VITEK 2 system and confirmed by polymerase chain reaction (PCR) targeting a Type III secretion system gene cluster. Multiplex PCR was performed to detect the genotypes of lipopolysaccharide (LPS) namely A, B, and B2, and singleplex PCR was performed to detect the presence of the <i>Burkholderia</i> intracellular motility gene ( <i>BimA</i> ) and filamentous hemagglutinin gene ( <i>fhaB3</i> ). <b>Statistical Analysis</b>  Chi-square/Fisher's exact tests were performed to study the association between various clinical manifestations and outcome and different virulence genes. The results were expressed as unadjusted odds ratios with 95% confidence intervals. <b>Results</b>  Sixty-seven isolates were available for characterization. <i>BimA <sub>Bm</sub></i> and <i>BimA <sub>Bp</sub></i> were observed among 82 and 18% of the isolates, respectively. Both sepsis and mortality were significantly associated with <i>BimA <sub>Bm</sub></i> . Majority of the isolates had <i>fhaB3</i> (97%). Most of the isolates showed the presence of LPS A gene (65.7%) followed by LPS B gene (6%), while LPS B2 was not detected. Nineteen isolates could not be assigned to any LPS genotypes. <b>Conclusion</b>  Among the virulence genes studied, only <i>BimA <sub>Bm</sub></i> was significantly associated with sepsis and mortality. More than a quarter (28.3%) of the isolates could not be assigned to any LPS genotypes, hinting at a greater genetic diversity in our isolates.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"276-281"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/7d/10-1055-s-0042-1760667.PMC10264109.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Anti-F-Actin Antibody Positivity on Indirect Immunofluorescence Assay Following Chinese and Alternative Medicine Therapy: A Case Report. 中西医结合替代药物治疗后间接免疫荧光检测抗f - actin抗体阳性1例。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1758663
Mala Mahto, Neha Rai, Soma Dey, Ramesh Kumar

Immunofluorescence on human epithelial type 2 cells is the standard screening assay for the detection of antinuclear antibodies (ANA). Cytoplasmic speckled patterns are a common finding. However, the less commonly reported ones include the cytoplasmic fibrillar patterns on indirect immunofluorescence technique (IIFT). The cytoplasmic fibrillar patterns include the cytoplasmic linear (AC-15), cytoplasmic filamentous (AC-16), and cytoplasmic segmental (AC-17). We report a case of cytoplasmic linear (F-actin) detected through IIFT during ANA screening in a 77-year-old man and later reconfirmed on liver mosaic biochip through IIFT on vascular smooth muscle substrate (VSM-47) without features suggestive of anti-smooth muscle antibody involvement post-complementary and alternative medicine therapy initiation.

人上皮2型细胞的免疫荧光是检测抗核抗体(ANA)的标准筛选方法。细胞质斑点型是一种常见的发现。然而,较少报道的包括间接免疫荧光技术(IIFT)的细胞质纤维模式。胞质纤维类型包括胞质线状(AC-15)、胞质丝状(AC-16)和胞质节段状(AC-17)。我们报告了一例77岁男性患者,在ANA筛查过程中通过IIFT检测到细胞质线状蛋白(F-actin),随后在肝脏嵌合生物芯片上通过血管平滑肌底物(VSM-47)的IIFT再次证实,在补充和替代药物治疗开始后,没有提示抗平滑肌抗体参与的特征。
{"title":"Anti-F-Actin Antibody Positivity on Indirect Immunofluorescence Assay Following Chinese and Alternative Medicine Therapy: A Case Report.","authors":"Mala Mahto,&nbsp;Neha Rai,&nbsp;Soma Dey,&nbsp;Ramesh Kumar","doi":"10.1055/s-0042-1758663","DOIUrl":"https://doi.org/10.1055/s-0042-1758663","url":null,"abstract":"<p><p>Immunofluorescence on human epithelial type 2 cells is the standard screening assay for the detection of antinuclear antibodies (ANA). Cytoplasmic speckled patterns are a common finding. However, the less commonly reported ones include the cytoplasmic fibrillar patterns on indirect immunofluorescence technique (IIFT). The cytoplasmic fibrillar patterns include the cytoplasmic linear (AC-15), cytoplasmic filamentous (AC-16), and cytoplasmic segmental (AC-17). We report a case of cytoplasmic linear (F-actin) detected through IIFT during ANA screening in a 77-year-old man and later reconfirmed on liver mosaic biochip through IIFT on vascular smooth muscle substrate (VSM-47) without features suggestive of anti-smooth muscle antibody involvement post-complementary and alternative medicine therapy initiation.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"311-315"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2b/72/10-1055-s-0042-1758663.PMC10264122.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Hemato-morphological Features in Neuroblastoma Infiltrating Marrow. 骨髓浸润性神经母细胞瘤的血液形态学研究。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1758667
Anurag Singh, Shalini Rawat, Geeta Yadav, Rashmi Kushwaha, Shailendra Prasad Verma, Uma S Singh

Objective  Neuroblastoma typically affects children within the first 5 years of life and accounts for 10% of all pediatric malignancies. Neuroblastoma at onset may manifest as a localized or metastatic illness. The aim of this study was to identify hematomorphological features in neuroblastoma infiltrating marrow as well as to ascertain the prevalence of bone marrow infiltration in neuroblastoma. Materials and Methods  This retrospective study included newly diagnosed 79 cases of neuroblastoma, which were referred for bone marrow examination for the staging of the disease. Medical records were retrieved to acquire hematomorphological findings of peripheral blood and bone marrow smears. Statistical Package for Social Sciences, IBM Inc., USA, version 21.0 was used to analyze the data. Results  The interquartile age range of neuroblastoma cases was 24.0 to 72.0 months (median = 48 months) with a male to female ratio of 2.7:1. Also, 55.6% (44/79) of cases in the study population showed evidence of marrow infiltration. The bone marrow infiltration was significantly linked to thrombocytopenia ( p  = 0.043) and nucleated red blood cells ( p  = 0.003) in peripheral blood. The bone marrow smears of cases with infiltration showed a significant shift to the left in the myeloid series ( p  = 0.001) and an increased number of erythroid cells ( p  = 0.001). Conclusion  For neuroblastoma patients, a diligent, exhaustive search for infiltrating cells in bone marrow is advised if thrombocytopenia or nucleated red blood cells are identified on a peripheral blood smear and bone marrow smears showed myeloid left shift with an increased number of erythroid cells.

目的神经母细胞瘤通常发生在儿童5岁以内,占所有儿童恶性肿瘤的10%。神经母细胞瘤发病时可表现为局部或转移性疾病。本研究的目的是确定骨髓浸润神经母细胞瘤的血液学特征,并确定骨髓浸润在神经母细胞瘤中的患病率。材料与方法回顾性研究新诊断的神经母细胞瘤79例,并行骨髓检查确定疾病分期。检索医疗记录,获取外周血和骨髓涂片的血液学结果。使用美国IBM公司的Statistical Package for Social Sciences, version 21.0对数据进行分析。结果神经母细胞瘤病例的四分位数年龄范围为24.0 ~ 72.0个月,中位年龄为48个月,男女比例为2.7:1。研究人群中55.6%(44/79)的病例显示骨髓浸润。骨髓浸润与血小板减少(p = 0.043)和外周血有核红细胞(p = 0.003)显著相关。骨髓浸润患者骨髓涂片显示髓系明显左移(p = 0.001),红细胞增多(p = 0.001)。结论:对于神经母细胞瘤患者,如果外周血涂片上发现血小板减少或有核红细胞,骨髓涂片显示骨髓左移,红细胞数量增加,建议仔细、详尽地搜索骨髓浸润细胞。
{"title":"Study of Hemato-morphological Features in Neuroblastoma Infiltrating Marrow.","authors":"Anurag Singh,&nbsp;Shalini Rawat,&nbsp;Geeta Yadav,&nbsp;Rashmi Kushwaha,&nbsp;Shailendra Prasad Verma,&nbsp;Uma S Singh","doi":"10.1055/s-0042-1758667","DOIUrl":"https://doi.org/10.1055/s-0042-1758667","url":null,"abstract":"<p><p><b>Objective</b>  Neuroblastoma typically affects children within the first 5 years of life and accounts for 10% of all pediatric malignancies. Neuroblastoma at onset may manifest as a localized or metastatic illness. The aim of this study was to identify hematomorphological features in neuroblastoma infiltrating marrow as well as to ascertain the prevalence of bone marrow infiltration in neuroblastoma. <b>Materials and Methods</b>  This retrospective study included newly diagnosed 79 cases of neuroblastoma, which were referred for bone marrow examination for the staging of the disease. Medical records were retrieved to acquire hematomorphological findings of peripheral blood and bone marrow smears. Statistical Package for Social Sciences, IBM Inc., USA, version 21.0 was used to analyze the data. <b>Results</b>  The interquartile age range of neuroblastoma cases was 24.0 to 72.0 months (median = 48 months) with a male to female ratio of 2.7:1. Also, 55.6% (44/79) of cases in the study population showed evidence of marrow infiltration. The bone marrow infiltration was significantly linked to thrombocytopenia ( <i>p</i>  = 0.043) and nucleated red blood cells ( <i>p</i>  = 0.003) in peripheral blood. The bone marrow smears of cases with infiltration showed a significant shift to the left in the myeloid series ( <i>p</i>  = 0.001) and an increased number of erythroid cells ( <i>p</i>  = 0.001). <b>Conclusion</b>  For neuroblastoma patients, a diligent, exhaustive search for infiltrating cells in bone marrow is advised if thrombocytopenia or nucleated red blood cells are identified on a peripheral blood smear and bone marrow smears showed myeloid left shift with an increased number of erythroid cells.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"224-229"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/bc/10-1055-s-0042-1758667.PMC10264124.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparative Review of ICMR, WHO, and EMA Guidelines for Good Clinical Laboratory Practices. ICMR、WHO和EMA良好临床实验室规范指南的比较回顾
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1757237
Rajat Kumar Joshi, Sudhir Chandra Sarangi, Sarita Mohapatra, Saumyaranjan Mallick, Sudip Kumar Datta

With the advancement of clinical research and the increased burden on laboratory services, there is an unmet need for guidelines regarding proper laboratory functioning and reliable data generation. Several organizations from all over the world have published guidelines for these clinical and research laboratories. Good Clinical Laboratory Practices (GCLP) are stepwise procedures aimed at strengthening the quality of test results produced by all clinical laboratories engaged in human sample analysis. In this article, we attempt a comparison of the GCLP guidelines recently issued by the Indian Council of Medical Research with the guidelines released by the World Health Organization and the European Medicines Agency. Also, we have included and discussed several suggestions that, if included, will lead to the strengthening of the laboratory practices used for both research and patient care for overall improvement in the Indian healthcare system.

随着临床研究的进展和实验室服务负担的增加,关于适当的实验室功能和可靠的数据生成的指南的需求尚未得到满足。来自世界各地的几个组织已经为这些临床和研究实验室发布了指南。良好临床实验室规范(GCLP)是旨在加强所有从事人体样本分析的临床实验室产生的检测结果质量的逐步程序。在本文中,我们试图将印度医学研究理事会最近发布的GCLP指南与世界卫生组织和欧洲药品管理局发布的指南进行比较。此外,我们还包括并讨论了一些建议,如果包括在内,将导致加强用于研究和患者护理的实验室实践,以全面改善印度医疗保健系统。
{"title":"A Comparative Review of ICMR, WHO, and EMA Guidelines for Good Clinical Laboratory Practices.","authors":"Rajat Kumar Joshi,&nbsp;Sudhir Chandra Sarangi,&nbsp;Sarita Mohapatra,&nbsp;Saumyaranjan Mallick,&nbsp;Sudip Kumar Datta","doi":"10.1055/s-0042-1757237","DOIUrl":"https://doi.org/10.1055/s-0042-1757237","url":null,"abstract":"<p><p>With the advancement of clinical research and the increased burden on laboratory services, there is an unmet need for guidelines regarding proper laboratory functioning and reliable data generation. Several organizations from all over the world have published guidelines for these clinical and research laboratories. Good Clinical Laboratory Practices (GCLP) are stepwise procedures aimed at strengthening the quality of test results produced by all clinical laboratories engaged in human sample analysis. In this article, we attempt a comparison of the GCLP guidelines recently issued by the Indian Council of Medical Research with the guidelines released by the World Health Organization and the European Medicines Agency. Also, we have included and discussed several suggestions that, if included, will lead to the strengthening of the laboratory practices used for both research and patient care for overall improvement in the Indian healthcare system.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"179-186"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/37/3a/10-1055-s-0042-1757237.PMC10264107.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9653282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of PD-L1 in Lung Carcinoma and Its Correlation with Histopathological Grade, Stage, and Survival of Patients. 肺癌组织中PD-L1的表达及其与患者病理分级、分期和生存的关系
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1758665
Vishesh Dhawan, Smita Chandra, Mansi Kala, Sushant Khanduri

Objective  PD-L1, a 40 kDa type 1 transmembrane protein, suppresses the adaptive arm of the immune system. The interaction of PD-1 with the ligand PD-L1 inhibits cytokine production and plays a role in the progression of lung cancer. The present study was performed to observe the expression of PD-L1 in lung carcinoma patients and its correlation with histopathological grade, stage, and survival of patients. Materials and Methods  This prospective study included all new cases of lung carcinoma diagnosed on histopathological or cytopathological examination over a period of 1 year. PD-L1 immunoexpression was statistically analyzed and graded according to the Tumor Proportion Score in all cases and correlated with histopathological grade, stage, and survival of patients. Results  This study included 56 cases of lung carcinoma with 64.2% cases showing PD-L1 positivity, out of which 44.6% were non-small cell and 19.6% were small cell lung carcinoma. In all, 32.1% cases with lymphovascular invasion, 53.5% with necrosis, and 37.5% cases with greater than 5/10 HPF mitotic figures showed positive PD-L1 expression. Paired cell blocks and histopathology showed 70% concordance for PD-L1 expression. 16.1% cT3N1M0 cases and 25% stage IIIA cases showed PD-L1 positivity. In all, 60.7% patients with positive PD-L1 expression did not survive for 12 months following diagnosis. Conclusion  PD-L1 immunoexpression was increased in lung carcinoma cases and was associated with poor histomorphological features including lymphovascular invasion, necrosis, and increased mitotic activity. PD-L1 correlated with cases having decreased 12-month survival and stage IIIA carcinoma. Thus, it may be useful in the stratification of patients who benefit from the PD-L1 targeted therapy.

目的PD-L1是一种40 kDa的1型跨膜蛋白,可抑制免疫系统的适应性臂。PD-1与配体PD-L1的相互作用抑制细胞因子的产生,并在肺癌的进展中发挥作用。本研究旨在观察PD-L1在肺癌患者中的表达及其与组织病理分级、分期及患者生存期的关系。材料与方法本前瞻性研究纳入1年内所有经组织病理学或细胞病理学检查诊断为肺癌的新病例。统计分析所有病例的PD-L1免疫表达,并根据肿瘤比例评分(Tumor Proportion Score)进行分级,并与患者的组织病理分级、分期、生存期相关。结果本组肺癌56例,PD-L1阳性64.2%,其中非小细胞肺癌占44.6%,小细胞肺癌占19.6%。其中淋巴血管浸润32.1%,坏死53.5%,HPF大于5/10的有丝分裂值37.5%为PD-L1阳性表达。配对细胞阻滞和组织病理学显示70%的PD-L1表达一致性。16.1%的cT3N1M0病例和25%的IIIA期病例显示PD-L1阳性。总的来说,60.7%的PD-L1表达阳性的患者在诊断后的12个月内无法存活。结论PD-L1免疫表达在肺癌中升高,并与淋巴血管侵袭、坏死、有丝分裂活性升高等组织形态学特征不良有关。PD-L1与12个月生存率降低和IIIA期癌相关。因此,它可能有助于从PD-L1靶向治疗中获益的患者分层。
{"title":"Expression of PD-L1 in Lung Carcinoma and Its Correlation with Histopathological Grade, Stage, and Survival of Patients.","authors":"Vishesh Dhawan,&nbsp;Smita Chandra,&nbsp;Mansi Kala,&nbsp;Sushant Khanduri","doi":"10.1055/s-0042-1758665","DOIUrl":"https://doi.org/10.1055/s-0042-1758665","url":null,"abstract":"<p><p><b>Objective</b>  PD-L1, a 40 kDa type 1 transmembrane protein, suppresses the adaptive arm of the immune system. The interaction of PD-1 with the ligand PD-L1 inhibits cytokine production and plays a role in the progression of lung cancer. The present study was performed to observe the expression of PD-L1 in lung carcinoma patients and its correlation with histopathological grade, stage, and survival of patients. <b>Materials and Methods</b>  This prospective study included all new cases of lung carcinoma diagnosed on histopathological or cytopathological examination over a period of 1 year. PD-L1 immunoexpression was statistically analyzed and graded according to the Tumor Proportion Score in all cases and correlated with histopathological grade, stage, and survival of patients. <b>Results</b>  This study included 56 cases of lung carcinoma with 64.2% cases showing PD-L1 positivity, out of which 44.6% were non-small cell and 19.6% were small cell lung carcinoma. In all, 32.1% cases with lymphovascular invasion, 53.5% with necrosis, and 37.5% cases with greater than 5/10 HPF mitotic figures showed positive PD-L1 expression. Paired cell blocks and histopathology showed 70% concordance for PD-L1 expression. 16.1% cT3N1M0 cases and 25% stage IIIA cases showed PD-L1 positivity. In all, 60.7% patients with positive PD-L1 expression did not survive for 12 months following diagnosis. <b>Conclusion</b>  PD-L1 immunoexpression was increased in lung carcinoma cases and was associated with poor histomorphological features including lymphovascular invasion, necrosis, and increased mitotic activity. PD-L1 correlated with cases having decreased 12-month survival and stage IIIA carcinoma. Thus, it may be useful in the stratification of patients who benefit from the PD-L1 targeted therapy.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"289-293"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/4c/10-1055-s-0042-1758665.PMC10264110.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9659444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Monocyte Distribution Width, a Novel Biomarker for Early Sepsis Screening and Comparison with Procalcitonin and C-Reactive Protein. 单核细胞分布宽度:早期脓毒症筛查的新生物标志物及与降钙素原和c反应蛋白的比较。
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1758666
Fatima Meraj, Sumera Shaikh, Sidra Maqsood, Fatima Kanani, Hamza Khan, Saba Jamal

Objectives  Monocyte distribution width (MDW) can be used for the early recognition of sepsis. The study compared the diagnostic accuracy of the MDW with two well-known sepsis biomarkers, procalcitonin (PCT) and C-reactive protein (CRP). Materials and Methods  A study was conducted from July 2021 to October 2021, on 111 patients admitted to the Indus Hospital and Health Network. Patients from the ages of 1 to 90 years were enrolled if hospitalized for more than 24 hours for suspected sepsis to avoid inclusion of patients who had short-term stay in the emergency department. According to the Sequential Organ Failure Assessment score, the clinical team did the characterization of cases as with sepsis or without sepsis. SPSS version 24 was used, and the diagnostic accuracy of MDW was assessed and compared using the area under the curves (AUCs) acquired from receiver operating characteristic curves. Pearson's chi-square/Fisher's exact test (as per need) was applied to determine the association. A p -value of less than 0.05 was considered significant. Results  Among 111 patients, 81 (73%) patients were labeled with sepsis and 30 (27%) were without sepsis. We have reported significantly higher MDW, PCT, and CRP levels in septic patients ( p  < 0.001). The AUC of MDW was comparable with PCT (0.794). Significant cutoff value for the MDW was greater than 20.24 U with 86% sensitivity and 73% specificity. Conclusion  MDW may have a predictive ability similar to PCT and CRP in terms of sepsis and, thus, can be used as a standard parameter for the timely diagnosis of sepsis.

目的单核细胞分布宽度(MDW)可用于脓毒症的早期识别。该研究比较了MDW与两种众所周知的脓毒症生物标志物降钙素原(PCT)和c反应蛋白(CRP)的诊断准确性。材料和方法研究于2021年7月至2021年10月对印度河医院和健康网络收治的111名患者进行了研究。年龄在1岁到90岁之间的患者,如果因疑似脓毒症住院超过24小时,则被纳入研究,以避免纳入在急诊科短期住院的患者。根据序期器官衰竭评估评分,临床小组对脓毒症或无脓毒症的病例进行了表征。采用SPSS version 24,利用从受试者工作特征曲线获得的曲线下面积(aus)对MDW的诊断准确性进行评估和比较。应用Pearson卡方检验/Fisher精确检验(根据需要)来确定相关性。p值小于0.05为显著性。结果111例患者中有81例(73%)脓毒症,30例(27%)无脓毒症。我们曾报道脓毒症患者MDW、PCT、CRP水平明显增高(p)。结论MDW对脓毒症的预测能力与PCT、CRP类似,可作为脓毒症及时诊断的标准参数。
{"title":"Monocyte Distribution Width, a Novel Biomarker for Early Sepsis Screening and Comparison with Procalcitonin and C-Reactive Protein.","authors":"Fatima Meraj,&nbsp;Sumera Shaikh,&nbsp;Sidra Maqsood,&nbsp;Fatima Kanani,&nbsp;Hamza Khan,&nbsp;Saba Jamal","doi":"10.1055/s-0042-1758666","DOIUrl":"https://doi.org/10.1055/s-0042-1758666","url":null,"abstract":"<p><p><b>Objectives</b>  Monocyte distribution width (MDW) can be used for the early recognition of sepsis. The study compared the diagnostic accuracy of the MDW with two well-known sepsis biomarkers, procalcitonin (PCT) and C-reactive protein (CRP). <b>Materials and Methods</b>  A study was conducted from July 2021 to October 2021, on 111 patients admitted to the Indus Hospital and Health Network. Patients from the ages of 1 to 90 years were enrolled if hospitalized for more than 24 hours for suspected sepsis to avoid inclusion of patients who had short-term stay in the emergency department. According to the Sequential Organ Failure Assessment score, the clinical team did the characterization of cases as with sepsis or without sepsis. SPSS version 24 was used, and the diagnostic accuracy of MDW was assessed and compared using the area under the curves (AUCs) acquired from receiver operating characteristic curves. Pearson's chi-square/Fisher's exact test (as per need) was applied to determine the association. A <i>p</i> -value of less than 0.05 was considered significant. <b>Results</b>  Among 111 patients, 81 (73%) patients were labeled with sepsis and 30 (27%) were without sepsis. We have reported significantly higher MDW, PCT, and CRP levels in septic patients ( <i>p</i>  < 0.001). The AUC of MDW was comparable with PCT (0.794). Significant cutoff value for the MDW was greater than 20.24 U with 86% sensitivity and 73% specificity. <b>Conclusion</b>  MDW may have a predictive ability similar to PCT and CRP in terms of sepsis and, thus, can be used as a standard parameter for the timely diagnosis of sepsis.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"294-299"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/ff/10-1055-s-0042-1758666.PMC10264128.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Characterization of Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolates and Their Antibiotic Resistance Profile in Health Care-Associated Urinary Tract Infections in North India. 北印度卫生保健相关尿路感染中产生β-内酰胺酶的大肠杆菌和肺炎克雷伯菌的广谱分子特征及其抗生素耐药性
IF 1.1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-06-01 DOI: 10.1055/s-0042-1757416
Sheetal Verma, Raj Kumar Kalyan, Prashant Gupta, Mohd Danish Khan, Vimala Venkatesh

Background  Healthcare-associated urinary tract infections (HAUTIs) caused by gram-negative pathogens have emerged as a global concern. So far, little is known about the epidemiology of extended-spectrum β lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in HAUTIs in India. The study was carried to determine the antibiotic resistance pattern and ESBL-producing genes in E. coli and K. pneumoniae strains isolated from HAUTIs in a tertiary institute in North India. Methods  A total of 200 consecutive, nonduplicate clinical isolates of E. coli and 140 isolates of K. pneumoniae from hospitalized patients with UTI were collected during a period of 1 year. Strains were studied for the presence of ESBL genes (blaCTX-M1, blaCTX-M2, blaCTX-M9, blaCTX-M15, blaSHV, blaTEM, blaOXA-1, blaVEB, blaPER-2, and blaGES) by multiplex polymerase chain reaction using gene-specific primers. Results  ESBL was detected in 82.5% (165 out of 200) isolates of E. coli and 74.3% (104 out of 140) isolates of K. pneumoniae by phenotypic confirmatory testing. From 269 phenotypically positive ESBL isolates, blaTEM (49.4%) was the most common genotype followed by blaCTX-M1 (31.97%), blaOXA-1 (30.1%), and blaSHV(11.9%) either alone or in combination. In the present study, blaCTX-M-15 (84.89%) was the most common blaCTX-M1-type ESBL. In total, 2.6 and 5.2% of the isolates were positive for PER-2 and VEB genes, respectively. Conclusion  To the best of our knowledge, this is the first study on ESBL resistance patterns and ESBL-producing genes in HAUTIs in North India. Our study reports high occurrence with ESBL types CTX-M-1, CTX-M-15, TEM, and SHV. Minor ESBL variants OXA-1, VEB-type, and PER-2-type β-lactamase are also emerging in HAUTIs infections in North India.

由革兰氏阴性病原体引起的卫生保健相关性尿路感染(HAUTIs)已成为全球关注的问题。迄今为止,对印度HAUTIs中产生广谱β内酰胺酶(ESBL)的大肠埃希菌和肺炎克雷伯菌的流行病学知之甚少。该研究是为了确定从印度北部一所高等院校的重症感染中分离的大肠杆菌和肺炎克雷伯菌菌株的抗生素耐药模式和产生esbl的基因。方法收集1年住院尿路感染患者连续分离的200株非重复临床分离的大肠杆菌和140株肺炎克雷伯菌。采用基因特异性引物进行多重聚合酶链反应,检测菌株是否存在ESBL基因(blaCTX-M1、blaCTX-M2、blaCTX-M9、blaCTX-M15、blaSHV、blaTEM、blaxa -1、blaVEB、blaPER-2和blaGES)。结果200株大肠杆菌中165株(82.5%)和140株肺炎克雷伯菌中104株(74.3%)经表型确证检测检出ESBL。在269株表型阳性的ESBL分离株中,最常见的基因型是blaTEM(49.4%),其次是blaCTX-M1(31.97%)、blaOXA-1(30.1%)和blaSHV(11.9%)。在本研究中,blaCTX-M-15(84.89%)是最常见的blactx - m1型ESBL。PER-2和VEB基因阳性率分别为2.6%和5.2%。据我们所知,这是对印度北部HAUTIs中ESBL抗性模式和产生ESBL基因的首次研究。我们的研究报告了ESBL型CTX-M-1、CTX-M-15、TEM和SHV的高发生率。轻微的ESBL变异OXA-1、veb型和per -2型β-内酰胺酶也出现在印度北部的HAUTIs感染中。
{"title":"Molecular Characterization of Extended Spectrum β-Lactamase Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Isolates and Their Antibiotic Resistance Profile in Health Care-Associated Urinary Tract Infections in North India.","authors":"Sheetal Verma,&nbsp;Raj Kumar Kalyan,&nbsp;Prashant Gupta,&nbsp;Mohd Danish Khan,&nbsp;Vimala Venkatesh","doi":"10.1055/s-0042-1757416","DOIUrl":"https://doi.org/10.1055/s-0042-1757416","url":null,"abstract":"<p><p><b>Background</b>  Healthcare-associated urinary tract infections (HAUTIs) caused by gram-negative pathogens have emerged as a global concern. So far, little is known about the epidemiology of extended-spectrum β lactamase (ESBL)-producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> in HAUTIs in India. The study was carried to determine the antibiotic resistance pattern and ESBL-producing genes in <i>E. coli</i> and <i>K. pneumoniae</i> strains isolated from HAUTIs in a tertiary institute in North India. <b>Methods</b>  A total of 200 consecutive, nonduplicate clinical isolates of <i>E. coli</i> and 140 isolates of <i>K. pneumoniae</i> from hospitalized patients with UTI were collected during a period of 1 year. Strains were studied for the presence of ESBL genes (blaCTX-M1, blaCTX-M2, blaCTX-M9, blaCTX-M15, blaSHV, blaTEM, blaOXA-1, blaVEB, blaPER-2, and blaGES) by multiplex polymerase chain reaction using gene-specific primers. <b>Results</b>  ESBL was detected in 82.5% (165 out of 200) isolates of <i>E. coli</i> and 74.3% (104 out of 140) isolates of <i>K. pneumoniae</i> by phenotypic confirmatory testing. From 269 phenotypically positive ESBL isolates, blaTEM (49.4%) was the most common genotype followed by blaCTX-M1 (31.97%), blaOXA-1 (30.1%), and blaSHV(11.9%) either alone or in combination. In the present study, blaCTX-M-15 (84.89%) was the most common blaCTX-M1-type ESBL. In total, 2.6 and 5.2% of the isolates were positive for <i>PER-2</i> and <i>VEB</i> genes, respectively. <b>Conclusion</b>  To the best of our knowledge, this is the first study on ESBL resistance patterns and ESBL-producing genes in HAUTIs in North India. Our study reports high occurrence with ESBL types CTX-M-1, CTX-M-15, TEM, and SHV. Minor ESBL variants OXA-1, VEB-type, and PER-2-type β-lactamase are also emerging in HAUTIs infections in North India.</p>","PeriodicalId":16149,"journal":{"name":"Journal of Laboratory Physicians","volume":"15 2","pages":"194-201"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/ac/10-1055-s-0042-1757416.PMC10264127.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9647089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Laboratory Physicians
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1